Delivery Order SPE2DB20D9136-SPE2DB22FJ58G

This is a $2,204.92 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The order is for the pharmaceutical product DALIRESP 500 MCG TABLET 90S, with a performance period through March 15, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle...

The Defense Logistics Agency Troop Support Medical awarded a $15,100.73 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562179744 DALIRESP 500 MCG TABLET 90S. The place of performance is Conshohocken, Pennsylvania. The period of performance is September 14, 2023 through September 15, 2023. No additional context was provided regarding the original solicitation or any associated contracts. The prime contractor is Amerisourcebergen Drug Corporation and there are no...

This is a delivery order under a Defense Logistics Agency (DLA) Indefinite Delivery Contract (IDC) awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The delivery order is for DALIRESP 500 MCG TABLET 90S, a pharmaceutical product, with a ceiling value of $1,600.86. The contract has an ultimate completion date of October 19, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical...

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of DALIRESP 500 MCG TABLET 30S. The contract, valued at $2,874.92, has a firm fixed price and an ultimate completion date of January 2, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...

This federal contract award, with identification number SPE2DB20D1100|SPE2DB25FB0D6, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,501.28, is for the delivery of DALIRESP 500 MCG TABLET 30S, a pharmaceutical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued...

This delivery order for $934 against the Defense Logistics Agency's pharmaceutical supply contract vehicle will procure 500 microgram DALIRESP tablets from Amerisourcebergen Drug Corporation. The 90-count tablets will be delivered to a location in Conshohocken, Pennsylvania by October 23, 2023. No set-aside provisions were applied to this firm fixed price award issued by DLA on October 20, 2023 to supply prescription medications in support of the Agency's mission to provide logistics support...

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,540.19 firm fixed-price delivery order is for the supply of DALIRESP 500 MCG TABLET 90S, a prescription medication. The award has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has established itself as a critical...

This federal contract award, valued at $4,204.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DALIRESP 500 MCG TABLET 30S, a medical product, and has an ultimate completion date of November 12, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...

The Defense Logistics Agency Troop Support Medical awarded a $12,581 delivery order to Amerisourcebergen Drug Corporation for 500 milligram DALIRESP tablets. Under the terms of the firm fixed price contract, Amerisourcebergen will deliver 90 tablets to a facility in Conshohocken, Pennsylvania by August 7, 2023. No additional details were provided regarding subcontractors or the underlying vehicle. The award is a straightforward order under the Medical Prime Vendor Program for a pharmaceutical...

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,232.46, is for the delivery of DALIRESP 250 MCG TABLET UU 28S, a pharmaceutical product. The contract has an ultimate completion date of February 26, 2025 and is a firm fixed-price delivery order. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...